Design and validation of a robust RP-UPLC approach for simultaneous quantification of emtricitabine, tenofovir, and nelfinavir in active pharmaceutical ingredients and finished dosage products
Background: Fixed-dose combinations of antiretroviral agents such as Emtricitabine (EMT), Tenofovir (TEN), and Nelfinavir (NEL) are central to Human Immunodeficiency Virus (HIV) therapy. Reliable quantification of these drugs is essential for pharmaceutical quality assurance and therapeutic drug mon...
Gorde:
| Egile Nagusiak: | , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Creative Pharma Assent
2026-03-01
|
| Saila: | Journal of Applied Pharmaceutical Research |
| Gaiak: | |
| Sarrera elektronikoa: | https://japtronline.com/index.php/joapr/article/view/1505 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|
